Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.2190
+0.0090 (4.29%)
At close: May 13, 2025, 4:00 PM
0.2229
+0.0039 (1.78%)
Pre-market: May 14, 2025, 8:43 AM EDT

Ernexa Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Revenue
0.540.580.07---
Upgrade
Revenue Growth (YoY)
365.22%755.88%----
Upgrade
Cost of Revenue
0.040.10.24---
Upgrade
Gross Profit
0.50.49-0.17---
Upgrade
Selling, General & Admin
10.4313.3214.7716.8414.723.3
Upgrade
Research & Development
4.264.415.7310.3912.713.95
Upgrade
Operating Expenses
14.6917.7420.5127.2327.437.25
Upgrade
Operating Income
-14.19-17.25-20.68-27.23-27.43-7.25
Upgrade
Interest Expense
-6.75-6.75-0.61-0.03-0.07-0.04
Upgrade
Interest & Investment Income
1.040.250.14---
Upgrade
Other Non Operating Income (Expenses)
-6.37-0.98-0.129.89-0-
Upgrade
EBT Excluding Unusual Items
-26.28-24.73-21.27-17.36-27.5-7.29
Upgrade
Merger & Restructuring Charges
-----5.77-
Upgrade
Gain (Loss) on Sale of Investments
---0.06-0.94--
Upgrade
Gain (Loss) on Sale of Assets
-----9.65-
Upgrade
Other Unusual Items
-19.78-19.780.12-0.240.97-
Upgrade
Pretax Income
-46.06-44.51-21.67-24.53-122.48-7.29
Upgrade
Income Tax Expense
0.030.03-00.050.06-
Upgrade
Net Income
-46.09-44.54-21.67-24.58-122.55-7.29
Upgrade
Preferred Dividends & Other Adjustments
0.020.020.020.020.02-
Upgrade
Net Income to Common
-46.11-44.56-21.68-24.6-122.56-7.29
Upgrade
Shares Outstanding (Basic)
26145321
Upgrade
Shares Outstanding (Diluted)
26145321
Upgrade
Shares Change (YoY)
376.06%156.81%74.17%40.92%146.19%-
Upgrade
EPS (Basic)
-1.80-3.26-4.08-8.06-56.61-8.29
Upgrade
EPS (Diluted)
-1.80-3.26-4.08-8.06-56.61-8.29
Upgrade
Free Cash Flow
-14.42-16.21-20.43-21.27-23.64-8.14
Upgrade
Free Cash Flow Per Share
-0.56-1.19-3.84-6.97-10.92-9.26
Upgrade
Gross Margin
93.46%83.50%-247.06%---
Upgrade
Operating Margin
-2652.90%-2963.92%-30404.41%---
Upgrade
Profit Margin
-8618.69%-7655.50%-31888.23%---
Upgrade
Free Cash Flow Margin
-2695.70%-2784.36%-30039.71%---
Upgrade
EBITDA
-14.08-17.11-20.59-27.07-27.31-7.15
Upgrade
D&A For EBITDA
0.120.140.080.160.120.1
Upgrade
EBIT
-14.19-17.25-20.68-27.23-27.43-7.25
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q